Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:17 pm Purchase |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
Abingworth LLP | 4,183,716 7.900% |
14,998 (+0.36%) |
Filing History |
| 2022-02-14 06:19 am Sale |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
Roche Finance Ltd | 2,334,113 4.400% |
-253,641 (-9.80%) |
Filing History |
| 2022-02-10 5:24 pm Purchase |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
4,246,664 8.000% |
49,886 (+1.19%) |
Filing History |
| 2022-02-10 08:42 am Purchase |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
The Vanguard Group | 3,134,286 5.940% |
3,134,286 (New Position) |
Filing History |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Vaxcyte, Inc. PCVX |
FMR LLC | 7,874,350 14.917% |
231,945 (+3.03%) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
BlackRock Inc. BLK |
2,777,047 5.300% |
2,777,047 (New Position) |
Filing History |
| 2022-01-18 5:22 pm Purchase |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
TPG GP A, LLC | 4,149,544 7.900% |
4,149,544 (New Position) |
Filing History |
| 2021-03-30 4:43 pm Purchase |
2021-03-24 | 13G | Vaxcyte, Inc. PCVX |
RA Capital Management, L.P. | 3,865,808 7.530% |
155,109 (+4.18%) |
Filing History |
| 2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Vaxcyte, Inc. PCVX |
RA Capital Management, L.P. | 3,710,699 7.300% |
-1,778,482 (-32.40%) |
Filing History |
| 2021-02-16 4:06 pm Purchase |
2020-12-31 | 13G | Vaxcyte, Inc. PCVX |
Abingworth LLP | 4,168,718 8.200% |
4,168,718 (New Position) |
Filing History |
| 2021-02-16 07:02 am Purchase |
2020-12-31 | 13G | Vaxcyte, Inc. PCVX |
Roche Finance Ltd | 2,587,754 5.100% |
2,587,754 (New Position) |
Filing History |
| 2021-02-12 5:12 pm Purchase |
2020-12-31 | 13G | Vaxcyte, Inc. PCVX |
Longitude Capital Partners II LLC | 3,108,780 6.100% |
3,108,780 (New Position) |
Filing History |
| 2021-02-12 4:57 pm Sale |
2020-12-31 | 13G | Vaxcyte, Inc. PCVX |
TPG Group Holdings (SBS) Advisors Inc. | 4,729,278 9.300% |
-427,275 (-8.29%) |
Filing History |
| 2021-02-12 3:52 pm Purchase |
2020-12-31 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
4,196,778 8.200% |
4,196,778 (New Position) |
Filing History |
| 2021-02-08 10:35 am Purchase |
2021-02-05 | 13G | Vaxcyte, Inc. PCVX |
FMR LLC | 7,642,405 14.999% |
1,972,357 (+34.79%) |
Filing History |
| 2020-08-10 09:25 am Purchase |
2020-08-07 | 13G | Vaxcyte, Inc. PCVX |
FMR LLC | 5,670,048 11.177% |
5,670,048 (New Position) |
Filing History |
| 2020-07-10 4:33 pm Purchase |
2020-06-30 | 13G | Vaxcyte, Inc. PCVX |
RA Capital Management, L.P. | 5,489,181 10.800% |
5,489,181 (New Position) |
Filing History |
| 2020-06-26 4:31 pm Purchase |
2020-06-16 | 13G | Vaxcyte, Inc. PCVX |
TPG Group Holdings (SBS) Advisors Inc. | 5,156,553 10.200% |
5,156,553 (New Position) |
Filing History |